Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Virus Res

Retrieve available abstracts of 126 articles:
HTML format

Single Articles

    October 2021
  1. FRANCESCHI VB, Ferrareze PAG, Zimerman RA, Cybis GB, et al
    Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021.
    Virus Res. 2021;304:198532.
    PubMed     Abstract available

  2. HUANG X, Zhang F, Zhu K, Lin W, et al
    dsmCRISPR: Dual synthetic mismatches CRISPR/Cas12a-based detection of SARS-CoV-2 D614G mutation.
    Virus Res. 2021;304:198530.
    PubMed     Abstract available

  3. FORT H
    A very simple model to account for the rapid rise of the alpha variant of SARS-CoV-2 in several countries and the world.
    Virus Res. 2021;304:198531.
    PubMed     Abstract available

  4. VALE FF, Vitor JMB, Marques AT, Azevedo-Pereira JM, et al
    Origin, phylogeny, variability and epitope conservation of SARS-CoV-2 worldwide.
    Virus Res. 2021;304:198526.
    PubMed     Abstract available

  5. ZHAO J, Wang L, Schank M, Dang X, et al
    SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
    Virus Res. 2021;304:198508.
    PubMed     Abstract available

  6. KANNIAN P, Jayaraman BG, Alamelu S, Lavanya C, et al
    Implications in the quantification of SARS-CoV2 copies in concurrent nasopharyngeal swabs, whole mouth fluid and respiratory droplets.
    Virus Res. 2021;303:198442.
    PubMed     Abstract available

    September 2021
  7. YANG F, Xiao Y, Liu F, Yao H, et al
    Molecular Characterization and Antigenic analysis of reassortant H9N2 subtype avian influenza viruses in Eastern China in 2016.
    Virus Res. 2021 Sep 21:198577. doi: 10.1016/j.virusres.2021.198577.
    PubMed     Abstract available

  8. YE H, Bi Z, Fan W, Song S, et al
    Cellular hnRNPAB interacts with avian influenza viral protein PB2 and inhibits virus replication potentially by restricting PB2 mRNA nuclear export and PB2 protein level.
    Virus Res. 2021 Sep 20:198573. doi: 10.1016/j.virusres.2021.198573.
    PubMed     Abstract available

  9. HAQUE MFU, Bukhari SS, Ejaz R, Zaman FU, et al
    A novel RdRp-based colorimetric RT-LAMP assay for rapid and sensitive detection of SARS-CoV-2 in clinical and sewage samples from Pakistan.
    Virus Res. 2021;302:198484.
    PubMed     Abstract available

  10. GORAICHUK IV, Arefiev V, Stegniy BT, Gerilovych AP, et al
    Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2.
    Virus Res. 2021;302:198473.
    PubMed     Abstract available

  11. EMAM M, Oweda M, Antunes A, El-Hadidi M, et al
    Positive selection as a key player for SARS-CoV-2 pathogenicity: Insights into ORF1ab, S and E genes.
    Virus Res. 2021;302:198472.
    PubMed     Abstract available

  12. STEGMANN KM, Dickmanns A, Gerber S, Nikolova V, et al
    The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models.
    Virus Res. 2021;302:198469.
    PubMed     Abstract available

    August 2021
  13. BURNHAM AJ, Miller JR, Singh I, Billings EA, et al
    Novel isoforms of influenza virus PA-X and PB1-F2 indicated by automatic annotation.
    Virus Res. 2021 Aug 12:198545. doi: 10.1016/j.virusres.2021.198545.
    PubMed     Abstract available

  14. POLICARD M, Jain S, Rego S, Dakshanamurthy S, et al
    Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
    Virus Res. 2021;301:198464.
    PubMed     Abstract available

    July 2021
  15. TIAN X, Mo C, Zhou L, Yang Y, et al
    Epitope mapping of severe acute respiratory syndrome-related coronavirus nucleocapsid protein with a rabbit monoclonal antibody.
    Virus Res. 2021;300:198445.
    PubMed     Abstract available

  16. HASSAN SS, Attrish D, Ghosh S, Choudhury PP, et al
    Pathogenic perspective of missense mutations of ORF3a protein of SARS-CoV-2.
    Virus Res. 2021;300:198441.
    PubMed     Abstract available

  17. RODRIGUEZ T, Dobrovolny HM
    Quantifying the effect of trypsin and elastase on in vitro SARS-CoV infections.
    Virus Res. 2021;299:198423.
    PubMed     Abstract available

  18. SALEHI-VAZIRI M, Omrani MD, Pouriayevali MH, Fotouhi F, et al
    SARS-CoV-2 presented moderately during two episodes of the infection with lack of antibody responses.
    Virus Res. 2021;299:198421.
    PubMed     Abstract available

  19. ALTABLE M, de la Serna JM
    Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets.
    Virus Res. 2021;299:198347.
    PubMed     Abstract available

    June 2021
  20. GHOSH N, Saha I, Sharma N, Nandi S, et al
    Genome-wide analysis of 10664 SARS-CoV-2 genomes to identify virus strains in 73 countries based on single nucleotide polymorphism.
    Virus Res. 2021;298:198401.
    PubMed     Abstract available

    Viral Vector DNA- and RNA-Based SARS-CoV-2 Vaccines: Possible Integration into the Human Genome Are Adenoviral Genes Expressed in Vector-based Vaccines?
    Virus Res. 2021 Jun 1:198466. doi: 10.1016/j.virusres.2021.198466.
    PubMed     Abstract available

    May 2021
  22. CARNEIRO DC, Sousa JD, Monteiro-Cunha JP
    The COVID-19 Vaccine Development: A Pandemic Paradigm.
    Virus Res. 2021 May 17:198454. doi: 10.1016/j.virusres.2021.198454.
    PubMed     Abstract available

  23. LEE S, Won D, Kim CK, Ahn J, et al
    Novel indel mutation in the N gene of SARS-CoV-2 clinical samples that were diagnosed positive in a commercial RT-PCR assay.
    Virus Res. 2021;297:198398.
    PubMed     Abstract available

  24. HASAN MM, Das R, Rasheduzzaman M, Hussain MH, et al
    Global and local mutations in Bangladeshi SARS-CoV-2 genomes.
    Virus Res. 2021;297:198390.
    PubMed     Abstract available

    April 2021
  25. FRANCISCO RDS JR, Benites LF, Lamarca AP, de Almeida LGP, et al
    Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil.
    Virus Res. 2021;296:198345.
    PubMed     Abstract available

  26. MIRANDA RL, Guterres A, de Azeredo Lima CH, Filho PN, et al
    Misinterpretation of viral load in COVID-19 clinical outcomes.
    Virus Res. 2021;296:198340.
    PubMed     Abstract available

  27. LI JY, Wang Q, Liao CH, Qiu Y, et al
    The 442th amino acid residue of the spike protein is critical for the adaptation to bat hosts for SARS-related coronaviruses.
    Virus Res. 2021;295:198307.
    PubMed     Abstract available

  28. SCAGNOLARI C, Pierangeli A, Frasca F, Bitossi C, et al
    Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19).
    Virus Res. 2021;295:198283.
    PubMed     Abstract available

  29. HU Z, Zhao J, Shi L, Hu J, et al
    Identification of the dominant non-neutralizing epitope in the haemagglutinin of H7N9 avian influenza virus.
    Virus Res. 2021;298:198409.
    PubMed     Abstract available

    March 2021
  30. LANDGRAF G, Desheva YA, Rudenko LG
    Evaluation of influenza A and B cold-adapted reassortant virus reproduction in trivalent live influenza vaccines.
    Virus Res. 2021 Mar 17:198396. doi: 10.1016/j.virusres.2021.198396.
    PubMed     Abstract available

  31. MIYAOKA Y, Kabir H, Hasan A, Yamaguchi M, et al
    Virucidal activity of slightly acidic hypochlorous acid water toward influenza virus and coronavirus with tests simulating practical usage.
    Virus Res. 2021 Mar 8:198383. doi: 10.1016/j.virusres.2021.198383.
    PubMed     Abstract available

  32. SAFARI F, Afarid M, Rastegari B, Borhani-Haghighi A, et al
    CRISPR systems: Novel approaches for detection and combating COVID-19.
    Virus Res. 2021;294:198282.
    PubMed     Abstract available

  33. TAN J, Yuan Y, Xu C, Song C, et al
    A retrospective comparison of drugs against COVID-19.
    Virus Res. 2021;294:198262.
    PubMed     Abstract available

    February 2021
  34. KIM DH, Park BJ, Ahn HS, Go HJ, et al
    Canine interferon lambda 3 expressed using an adenoviral vector effectively induces antiviral activity against canine influenza virus.
    Virus Res. 2021 Feb 16:198342. doi: 10.1016/j.virusres.2021.198342.
    PubMed     Abstract available

  35. RIVERA-BAHENA GB, Marquez-Bandala AH, Lopez-Guerrero DV, Esquivel-Guadarrama FR, et al
    TGF-beta1 signaling inhibit the in vitro apoptotic, infection and stimulatory cell response induced by influenza H1N1 virus infection on A549 cells.
    Virus Res. 2021 Feb 10:198337. doi: 10.1016/j.virusres.2021.198337.
    PubMed     Abstract available

  36. LI B, Xiang G, He J, Li H, et al
    H7N9 influenza virus surveillance in Gansu, China in 2017.
    Virus Res. 2021 Feb 9:198335. doi: 10.1016/j.virusres.2021.198335.
    PubMed     Abstract available

  37. DE CONTO F, Conversano F, Razin SV, Belletti S, et al
    Host-cell dependent role of phosphorylated keratin 8 during influenza A/NWS/33 virus (H1N1) infection in mammalian cells.
    Virus Res. 2021 Feb 5:198333. doi: 10.1016/j.virusres.2021.198333.
    PubMed     Abstract available

  38. AKIYAMA Y, Sakashita K, Arihara M, Kimura Y, et al
    COVID-19 infection in Hokkaido, Japan might depend on the viscosity of atmospheric air.
    Virus Res. 2021;293:198259.
    PubMed     Abstract available

  39. ITO G, Morikawa M, Akimoto S, Masatani T, et al
    Establishment of a safe and convenient assay for detection of HA subtype-specific antibodies with PB2 gene-knockout influenza viruses.
    Virus Res. 2021 Feb 1:198331. doi: 10.1016/j.virusres.2021.198331.
    PubMed     Abstract available

    January 2021
  40. LUBAN J, Sattler RA, Muhlberger E, Graci JD, et al
    The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines.
    Virus Res. 2021;292:198246.
    PubMed     Abstract available

  41. KUMAR R, Rathi H, Haq A, Wimalawansa SJ, et al
    Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
    Virus Res. 2021;292:198235.
    PubMed     Abstract available

  42. JOONLASAK K, Batty EM, Kochakarn T, Panthan B, et al
    Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a.
    Virus Res. 2021;292:198233.
    PubMed     Abstract available

  43. MALEK A, Hoque A
    Trends of 2019-nCoV in South Asian countries and prediction of the epidemic peaks.
    Virus Res. 2021;292:198230.
    PubMed     Abstract available

  44. CATTEL F, Giordano S, Bertiond C, Lupia T, et al
    Ozone therapy in COVID-19: A narrative review.
    Virus Res. 2021;291:198207.
    PubMed     Abstract available

  45. PIERETTI JC, Rubilar O, Weller RB, Tortella GR, et al
    Nitric oxide (NO) and nanoparticles - Potential small tools for the war against COVID-19 and other human coronavirus infections.
    Virus Res. 2021;291:198202.
    PubMed     Abstract available

  46. CABBAB ILN, Manalo RVM
    Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: Current knowledge and potential effects on early SARS-CoV-2 infection.
    Virus Res. 2021;291:198190.
    PubMed     Abstract available

    December 2020
  47. TAHAGHOGHI-HAJGHORBANI S, Zafari P, Masoumi E, Rajabinejad M, et al
    The role of dysregulated immune responses in COVID-19 pathogenesis.
    Virus Res. 2020;290:198197.
    PubMed     Abstract available

  48. RAJEEV R, Prathiviraj R, Kiran GS, Selvin J, et al
    Zoonotic evolution and implications of microbiome in viral transmission and infection.
    Virus Res. 2020;290:198175.
    PubMed     Abstract available

  49. KILLICK R, Ballard C, Doherty P, Williams G, et al
    Transcription-based drug repurposing for COVID-19.
    Virus Res. 2020;290:198176.
    PubMed     Abstract available

  50. KHARE P, Sahu U, Pandey SC, Samant M, et al
    Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Virus Res. 2020;290:198169.
    PubMed     Abstract available

  51. FREIRE-PASPUEL B, Vega-Marino P, Velez A, Cruz M, et al
    "Sample pooling of RNA extracts to speed up SARS-CoV-2 diagnosis using CDC FDA EUA RT-qPCR kit".
    Virus Res. 2020;290:198173.
    PubMed     Abstract available

  52. YAMASAKI Y, Ooka S, Tsuchida T, Nakamura Y, et al
    The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide.
    Virus Res. 2020;290:198089.
    PubMed     Abstract available

    November 2020
  53. WEBER S, Ramirez C, Doerfler W
    Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world.
    Virus Res. 2020;289:198170.
    PubMed     Abstract available

  54. GADOTTI AC, de Castro Deus M, Telles JP, Wind R, et al
    IFN-gamma is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection.
    Virus Res. 2020;289:198171.
    PubMed     Abstract available

  55. RANGEL HR, Ortega JT, Maksoud S, Pujol FH, et al
    SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.
    Virus Res. 2020;289:198154.
    PubMed     Abstract available

  56. ELHABYAN A, Elyaacoub S, Sanad E, Abukhadra A, et al
    The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review.
    Virus Res. 2020;289:198163.
    PubMed     Abstract available

  57. WANG X, Zheng J, Guo L, Yao H, et al
    Fecal viral shedding in COVID-19 patients: Clinical significance, viral load dynamics and survival analysis.
    Virus Res. 2020;289:198147.
    PubMed     Abstract available

  58. MARDANI R, Alamdary A, Mousavi Nasab SD, Gholami R, et al
    Association of vitamin D with the modulation of the disease severity in COVID-19.
    Virus Res. 2020;289:198148.
    PubMed     Abstract available

  59. CHOUDHARY S, Silakari O
    Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19.
    Virus Res. 2020;289:198146.
    PubMed     Abstract available

    October 2020
  60. ZHOU Y, Wu X, Yan D, Chen C, et al
    V292I Mutation in PB2 Polymerase Induces Increased Effects of E627K on Influenza H7N9 Virus Replication in Cells.
    Virus Res. 2020 Oct 16:198186. doi: 10.1016/j.virusres.2020.198186.
    PubMed     Abstract available

  61. YOKOYAMA Y, Briasoulis A, Takagi H, Kuno T, et al
    Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials.
    Virus Res. 2020;288:198137.
    PubMed     Abstract available

  62. ALI Z, Aman R, Mahas A, Rao GS, et al
    iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2.
    Virus Res. 2020;288:198129.
    PubMed     Abstract available

  63. DUTTA R, Buragohain L, Borah P
    Analysis of codon usage of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and its adaptability in dog.
    Virus Res. 2020;288:198113.
    PubMed     Abstract available

  64. MOHAMMAD T, Shamsi A, Anwar S, Umair M, et al
    Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.
    Virus Res. 2020;288:198102.
    PubMed     Abstract available

  65. SITARAS I, Spackman E, de Jong MCM, Parris DJ, et al
    Selection and Antigenic Characterization of Immune-Escape Mutants of H7N2 Low Pathogenic Avian Influenza Virus Using Homologous Polyclonal Sera.
    Virus Res. 2020 Oct 9:198188. doi: 10.1016/j.virusres.2020.198188.
    PubMed     Abstract available

  66. BAHRAMPOUR JUYBARI K, Pourhanifeh MH, Hosseinzadeh A, Hemati K, et al
    Melatonin potentials against viral infections including COVID-19: Current evidence and new findings.
    Virus Res. 2020;287:198108.
    PubMed     Abstract available

  67. VAN DEN HOOGEN B, Santoni A, Sciume G, Bowie A, et al
    Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.
    Virus Res. 2020;287:198094.
    PubMed     Abstract available

  68. KESZEI Z, Vendrell XM, Soultsioti M, Molina PR, et al
    100 days of solitude: The spring of COVID-19 through the eyes of 15 young virologists of the INITIATE program.
    Virus Res. 2020;287:198093.

  69. NIE Q, Li X, Chen W, Liu D, et al
    Phylogenetic and phylodynamic analyses of SARS-CoV-2.
    Virus Res. 2020;287:198098.
    PubMed     Abstract available

    September 2020
  70. AHLAWAT S, Asha, Sharma KK
    Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
    Virus Res. 2020;286:198103.
    PubMed     Abstract available

  71. LI C, Wang L, Ren L
    Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.
    Virus Res. 2020;286:198073.
    PubMed     Abstract available

  72. MAGRO G
    COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking.
    Virus Res. 2020;286:198070.
    PubMed     Abstract available

  73. ROMEO A, Iacovelli F, Falconi M
    Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
    Virus Res. 2020;286:198068.
    PubMed     Abstract available

  74. PAN X, Dong L, Yang L, Chen D, et al
    Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China.
    Virus Res. 2020;286:198057.
    PubMed     Abstract available

  75. BEHLOUL N, Baha S, Shi R, Meng J, et al
    Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.
    Virus Res. 2020;286:198058.
    PubMed     Abstract available

  76. LI J, Wei X, Tian W, Zou J, et al
    Clinical features of discharged COVID-19 patients with an extended SARS-CoV-2 RNA positive signal in respiratory samples.
    Virus Res. 2020;286:198047.

  77. LI J, Gong X, Wang Z, Chen R, et al
    Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China.
    Virus Res. 2020;286:198043.
    PubMed     Abstract available

  78. POST A, Dullaart RPF, Bakker SJL
    Sodium status and kidney involvement during COVID-19 infection.
    Virus Res. 2020;286:198034.
    PubMed     Abstract available

    August 2020
  79. SAMRAT SK, Tharappel AM, Li Z, Li H, et al
    Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development.
    Virus Res. 2020 Aug 23:198141. doi: 10.1016/j.virusres.2020.198141.
    PubMed     Abstract available

  80. WENJUN M
    Swine Influenza Virus: Current Status and Challenge.
    Virus Res. 2020 Aug 13:198118. doi: 10.1016/j.virusres.2020.198118.
    PubMed     Abstract available

  81. KAUR SP, Gupta V
    COVID-19 Vaccine: A comprehensive status report.
    Virus Res. 2020 Aug 12:198114. doi: 10.1016/j.virusres.2020.198114.
    PubMed     Abstract available

  82. DHAR D, Mohanty A
    Gut microbiota and Covid-19- possible link and implications.
    Virus Res. 2020;285:198018.
    PubMed     Abstract available

  83. ONAWOLE AT, Sulaiman KO, Kolapo TU, Akinde FO, et al
    COVID-19: CADD to the rescue.
    Virus Res. 2020;285:198022.
    PubMed     Abstract available

  84. ZHU X, Ge Y, Wu T, Zhao K, et al
    Co-infection with respiratory pathogens among COVID-2019 cases.
    Virus Res. 2020;285:198005.
    PubMed     Abstract available

  85. WANG Y, Song W, Zhao Z, Chen P, et al
    The impacts of viral inactivating methods on quantitative RT-PCR for COVID-19.
    Virus Res. 2020;285:197988.
    PubMed     Abstract available

    July 2020
  86. MANI JS, Johnson JB, Steel JC, Broszczak DA, et al
    Natural product-derived phytochemicals as potential agents against coronaviruses: A review.
    Virus Res. 2020;284:197989.
    PubMed     Abstract available

  87. ABUSALAMAH H, Reel JM, Lupfer CR
    Pyruvate Affects Inflammatory Responses of Macrophages During Influenza A Virus Infection.
    Virus Res. 2020 Jul 4:198088. doi: 10.1016/j.virusres.2020.198088.
    PubMed     Abstract available

  88. LIN L, Ting S, Yufei H, Wendong L, et al
    Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
    Virus Res. 2020 Jul 1:198082. doi: 10.1016/j.virusres.2020.198082.
    PubMed     Abstract available

    June 2020
  89. FANG A, Bi Z, Ye H, Yan L, et al
    SRSF10 inhibits the polymerase activity and replication of avian influenza virus by regulating the alternative splicing of chicken ANP32A.
    Virus Res. 2020 Jun 20:198063. doi: 10.1016/j.virusres.2020.198063.
    PubMed     Abstract available

    March 2020
  90. GODBOLE NM, Sinha RA, Tiwari S, Pawar SD, et al
    Analysis of influenza virus-induced perturbation in autophagic flux and its modulation during Vitamin D3 mediated anti-apoptotic signaling.
    Virus Res. 2020 Mar 28:197936. doi: 10.1016/j.virusres.2020.197936.
    PubMed     Abstract available

    January 2020
  91. ZHENG B, Zhou J, Wang H
    Host microRNAs and exosomes that modulate influenza virus infection.
    Virus Res. 2020 Jan 22:197885. doi: 10.1016/j.virusres.2020.197885.
    PubMed     Abstract available

    December 2019
  92. DE VRIES RD, Nieuwkoop NJ, Krammer F, Hu B, et al
    Analysis Of The Vaccine-Induced Influenza B Virus Hemagglutinin-Specific Antibody Dependent Cellular Cytotoxicity Response.
    Virus Res. 2019 Dec 11:197839. doi: 10.1016/j.virusres.2019.197839.
    PubMed     Abstract available

    October 2019
  93. LIU Y, Xie W, Chi M, Wen H, et al
    Mutations in the HRB linker of Human Parainfluenza Virus Type 3 Fusion Protein Reveal its Importance for Fusion Activity.
    Virus Res. 2019 Oct 16:197791. doi: 10.1016/j.virusres.2019.197791.
    PubMed     Abstract available

    August 2019
  94. VAZQUEZ-PEREZ JA, De La Rosa-Zamboni D, Vega-Sanchez Angel E, Gutierrez-Gonzalez LH, et al
    Amino acid changes in HA and determinants of pathogenicity associated with influenza virus A H1N1pdm09 during the winter seasons 2015-2016 and 2016-2017 in Mexico.
    Virus Res. 2019;272:197731.
    PubMed     Abstract available

    June 2019
  95. LEEMANS A, Boeren M, Van der Gucht W, Martinet W, et al
    Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity.
    Virus Res. 2019;266:58-68.
    PubMed     Abstract available

    March 2019
  96. HSIEH MS, Chang YC, He JL, Juang RH, et al
    Positive charge of Arg-201 on hemagglutinin is required for the binding of H6N1 avian influenza virus to its target through a two-step process.
    Virus Res. 2019;265:132-137.
    PubMed     Abstract available

  97. KODE SS, Pawar SD, Cherian SS, Tare DS, et al
    Selection of avian influenza A (H9N2) virus with reduced susceptibility to neuraminidase inhibitors oseltamivir and zanamivir.
    Virus Res. 2019 Mar 22. pii: S0168-1702(18)30554.
    PubMed     Abstract available

    February 2019
  98. ILYUSHINA NA, Dickensheets H, Donnelly RP
    A comparison of interferon gene expression induced by influenza A virus infection of human airway epithelial cells from two different donors.
    Virus Res. 2019 Feb 16. pii: S0168-1702(18)30652.
    PubMed     Abstract available

    January 2019
  99. BO F, Yang WT, Shonyela SM, Jin YB, et al
    Immune responses of mice inoculated with recombinant Lactobacillus plantarum NC8 expressing the fusion gene HA2 and 3M2e of the influenza virus and protection against different subtypes of influenza virus.
    Virus Res. 2019 Jan 3. pii: S0168-1702(18)30308.
    PubMed     Abstract available

    December 2018
  100. GAO J, Gao L, Li R, Lai Z, et al
    Integrated analysis of microRNA-mRNA expression in A549 cells infected with influenza A viruses (IAVs) from different host species.
    Virus Res. 2018 Dec 31. pii: S0168-1702(18)30568.
    PubMed     Abstract available

    October 2018
  101. MOHEBBI A, Fotouhi F, Jamali A, Yaghobi R, et al
    Molecular Epidemiology of the Hemagglutinin gene of prevalent influenza virus A/H1N1/pdm09 among patient in Iran.
    Virus Res. 2018 Oct 15. pii: S0168-1702(18)30478.
    PubMed     Abstract available

    September 2018
  102. MARUYAMA H, Kimura T, Liu H, Ohtsuki S, et al
    Influenza virus replication raises the temperature of cells.
    Virus Res. 2018 Sep 21. pii: S0168-1702(17)30886.
    PubMed     Abstract available

  103. HUO C, Jin Y, Zou S, Qi P, et al
    Lethal influenza A virus preferentially activates TLR3 and triggers a severe inflammatory response.
    Virus Res. 2018 Sep 21. pii: S0168-1702(18)30215.
    PubMed     Abstract available

    May 2018
  104. LUO J, Lu G, Ye S, Ou J, et al
    Comparative pathogenesis of H3N2 canine influenza virus in beagle dogs challenged by intranasal and intratracheal inoculation.
    Virus Res. 2018 May 31. pii: S0168-1702(18)30084.
    PubMed     Abstract available

  105. ZHANG F, Wang S, Wang Y, Shang X, et al
    Characterization of pseudoparticles paired with hemagglutinin and neuraminidase from highly pathogenic H5N1 influenza and avian influenza A (H7N9) viruses.
    Virus Res. 2018;253:20-27.
    PubMed     Abstract available

  106. RUDNEVA IA, Timofeeva TA, Mukasheva EA, Ignatieva AV, et al
    Pleiotropic effects of hemagglutinin amino acid substitutions of influenza A(H1N1)pdm09 virus escape mutants.
    Virus Res. 2018;251:91-97.
    PubMed     Abstract available

  107. CHEN L, Xing C, Ma G, Luo J, et al
    N-Myc Downstream-Regulated Gene 1 Facilitates Influenza A Virus Replication by Suppressing Canonical NF-kappaB Signaling.
    Virus Res. 2018 May 3. pii: S0168-1702(17)30905.
    PubMed     Abstract available

  108. SHOKOUHI H, Farahmand B, Ghaemi A, Mazaheri V, et al
    Vaccination with three tandem repeats of M2 extracellular domain fused to Leismania major HSP70 protects mice against influenza A virus challenge.
    Virus Res. 2018;251:40-46.
    PubMed     Abstract available

    March 2018
  109. SUPTAWIWAT O, Kongchanagul A, Boonarkart C, Auewarakul P, et al
    H1N1 seasonal influenza virus evolutionary rate changed over time.
    Virus Res. 2018 Mar 30. pii: S0168-1702(17)30881.
    PubMed     Abstract available

  110. ZHANG D, Lin G, Zhang K, Yi L, et al
    Implications of and lessons learned from external assurance of eight influenza diagnostics in China.
    Virus Res. 2018;249:110-115.
    PubMed     Abstract available

    February 2018
  111. CHOI SY, Cho B
    Extermination of influenza virus H1N1 by a new visible-light-induced photocatalyst under fluorescent light.
    Virus Res. 2018 Feb 21. pii: S0168-1702(17)30789.
    PubMed     Abstract available

    January 2018
  112. KALENIK BM, Gora-Sochacka A, Sirko A
    Beta-defensins - Underestimated peptides in influenza combat.
    Virus Res. 2018;247:10-14.
    PubMed     Abstract available

  113. KIM Y, Chang KO
    Protein Disulfide Isomerases as potential therapeutic targets for Influenza A and B Viruses.
    Virus Res. 2018 Jan 27. pii: S0168-1702(17)30675.
    PubMed     Abstract available

    November 2017
  114. YU Z, Cheng K, Sun W, Zhang X, et al
    Multiple adaptive amino acid substitutions increase the virulence of a wild waterfowl-origin reassortant H5N8 avian influenza virus in mice.
    Virus Res. 2017 Nov 4. pii: S0168-1702(17)30493.
    PubMed     Abstract available

    September 2017
  115. WANG Y, Zhang Y, Wu J, Lin Y, et al
    Recombinant influenza H7 hemagglutinin containing CFLLC minidomain in the transmembrane domain showed enhanced cross-protection in mice.
    Virus Res. 2017;242:16-23.
    PubMed     Abstract available

    July 2017
  116. PLANT EP, Ilyushina NA, Sheikh F, Donnelly RP, et al
    Influenza Virus NS1 Protein Mutations at Position 171 Impact Innate Interferon Responses by Respiratory Epithelial Cells.
    Virus Res. 2017 Jul 27. pii: S0168-1702(17)30201.
    PubMed     Abstract available

  117. KHAN A, Mushtaq MH, Ahmad MUD, Nazir J, et al
    Molecular Epidemiology of a novel re-assorted epidemic strain of equine influenza virus in Pakistan in 2015-16.
    Virus Res. 2017 Jul 27. pii: S0168-1702(17)30256.
    PubMed     Abstract available

    June 2017
  118. MANITO ACB, Graf T, Lunge VR, Ikuta N, et al
    Spatiotemporal dynamics of influenza A(H1N1)pdm09 in Brazil during the pandemic and post-pandemic periods.
    Virus Res. 2017 Jun 3. pii: S0168-1702(17)30047.
    PubMed     Abstract available

  119. NINPAN K, Suptawiwat O, Boonarkart C, Songprakhon P, et al
    Mutations in Matrix Protein 1 and Nucleoprotein caused Human-Specific Defects in Nuclear Exportation and Viral Assembly of an Avian Influenza H7N1 Virus.
    Virus Res. 2017 Jun 1. pii: S0168-1702(16)30771.
    PubMed     Abstract available

    April 2017
  120. FULTON RW, Neill JD, Saliki JT, Landis C, et al
    Genomic and antigenic characterization of bovine parainfluenza-3 viruses in the United States including modified live virus vaccine (MLV) strains and field strains from cattle.
    Virus Res. 2017 Apr 14. pii: S0168-1702(17)30110.
    PubMed     Abstract available

  121. IZZARD L, Dlugolenski D, Xia Y, McMahon M, et al
    Enhanced immunogenicity following miR-155 incorporation into the influenza A virus genome.
    Virus Res. 2017 Apr 6. pii: S0168-1702(16)30814.
    PubMed     Abstract available

    March 2017
  122. SELVARANI V, Roland S, Andy S, James H, et al
    Prevention of influenza virus induced bacterial superinfection by standardized Echinacea purpurea, via regulation of surface receptor expression in human bronchial epithelial cells.
    Virus Res. 2017 Mar 6. pii: S0168-1702(16)30783.
    PubMed     Abstract available

    January 2017
  123. PFLUG A, Lukarska M, Resa-Infante P, Reich S, et al
    Structural insights into RNA synthesis by the influenza virus transcription-replication machine.
    Virus Res. 2017 Jan 20. pii: S0168-1702(16)30782.
    PubMed     Abstract available

    November 2016
  124. ABDELWHAB EM, Veits J, Mettenleiter TC
    Biological fitness and natural selection of amantadine resistant variants of avian influenza H5N1 viruses.
    Virus Res. 2016;228:109-113.
    PubMed     Abstract available

    October 2016
    Structural and functional specificity of Influenza virus haemagglutinin and paramyxovirus fusion protein anchoring peptides.
    Virus Res. 2016 Oct 20. pii: S0168-1702(16)30406.
    PubMed     Abstract available

    January 2016
  126. ASENJO A, Villanueva N
    Phosphorylation of the human respiratory syncytial virus P protein mediates M2-2 regulation of viral RNA synthesis, a process that involves two P proteins.
    Virus Res. 2016;211:117-25.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.